Houle S, DaSilva J N, Wilson A A
Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health, Toronto, Canada.
Nucl Med Biol. 2000 Jul;27(5):463-6. doi: 10.1016/s0969-8051(00)00112-8.
This paper summarizes our work on WAY-100635 and analogues, labeled either with carbon-11 or fluorine-18, as potential radioligands for the 5-hydroxytryptamine(1A) (5-HT(1A)) neuroreceptors. Other facets of our work include: (1) human studies with [O-methyl-(11)C]WAY-100634, the major radioactive metabolite of [O-methyl-(11)C]WAY-100635, and with [(11)C]CPC 222; (2) use of a human liver metabolism model to screen in vitro potential metabolic problems in humans; (3) modification of the "dry method" to prepare [carbonyl-(11)C]WAY-100635; and (4) validation studies in humans with [carbonyl-(11)C]WAY-100635.
本文总结了我们在WAY-100635及其类似物方面的工作,这些类似物用碳-11或氟-18标记,作为5-羟色胺(1A)(5-HT(1A))神经受体的潜在放射性配体。我们工作的其他方面包括:(1)使用[O-甲基-(11)C]WAY-100634([O-甲基-(11)C]WAY-100635的主要放射性代谢物)和[(11)C]CPC 222进行人体研究;(2)使用人体肝脏代谢模型在体外筛选人体潜在的代谢问题;(3)改进“干法”以制备[羰基-(11)C]WAY-100635;以及(4)用[羰基-(11)C]WAY-100635在人体进行验证研究。